4-(2-Methyl-1H-Imidazol-1-Yl)-2,2-Diphenylbutanamide 4-(2-甲基-1H-咪唑-1-基)-2,2-二苯基丁酰胺
CAS 170105-16-5 MFCD09833703
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Pharmaceuticals
- Amines
- Heterocycles
- Intermediates & Fine Chemicals
- {SNA} Building Blocks, C9 to C30+, Chemical Synthesis, Heterocyclic Building Blocks, Imidazoles
产品应用
- A novel therapeutic agent for overactive bladder with antimuscarinic activity, on mediator release from urothelium and detrusor overactivity induced by cerebral infarction. A muscarinic antagonist.
相关文献及参考
- [2]. Yamazaki T, et al. Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats. Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1095-102.
- Andersson, K., et al.: Eur. Urol., 43, 1 (2003),
- Kullmann, F., et al.: J. Neurosci., 28, 1977 (2008),
- Wang, X., et al.: Biomed. Res. 29, 105 (2008),
- [1]. Miyachi H, et al. Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agents. Bioorg Med Chem. 1999 Jun;7(6):1151-61.
- [1]. Miyachi H, et al. Synthesis and antimuscarinic activity of a series of 4-(1-Imidazolyl)-2,2-diphenylbutyramides: discovery of potent and subtype-selective antimuscarinic agents. Bioorg Med Chem. 1999 Jun;7(6):1151-61.
- [2]. Yamazaki T, et al. Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats. Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1095-102.